Showing posts with label Capital Product Partners. Show all posts
Showing posts with label Capital Product Partners. Show all posts

Wednesday, August 3, 2011

MedAssets (MDAS) (HUM) (SNCR) (DLR) (FRO) (ARIA) (ALGT) (CPLP) (GEVO) Price Targets Changed

MedAssets, Inc. (NASDAQ: MDAS), Humana (NYSE: HUM), Synchronoss Technologies, Inc. (NASDAQ: SNCR), Digital Realty Trust, Inc. (NYSE: DLR), Frontline Ltd. (NYSE: FRO), Ariad Pharmaceutical (NASDAQ: ARIA), Allegiant Travel (NASDAQ: ALGT), Capital Product Partners L.P. (NASDAQ: CPLP) and Gevo, Inc. (NASDAQ: GEVO) price targets adjusted by analysts.

MedAssets, Inc. (MDAS) had its price target lowered by UBS AG (NYSE:UBS) from $15.50 to $13.00. The have a “Neutral” rating on the company.

Humana (NYSE: HUM) had its price target raised by Barclays Capital from $85.00 to $90.00. They have an “Equal Weight” rating on the company.

Synchronoss Technologies, Inc. (SNCR) had its price target raised by Stifel Nicolaus from $38.00 to $44.00. They have a “Buy” rating on the company.

Digital Realty Trust, Inc. (DLR) had its price target lowered by Barclays Capital from $70.00 to $67.00. They have an “Overweight” rating on the company.

Frontline Ltd. (FRO) had its price target lowered by Deutsche Bank (NYSE:DB) from $22.00 to $16.00. They have a “Buy” rating on the company.

Ariad Pharmaceutical (ARIA) had its price target raised by Brean Murray from $11.00 to $15.00. They have a “Buy” rating on the company.

Allegiant Travel (ALGT) had its price target cut by Barclays Capital from $65.00 to $61.00. They have an “Overweight” rating on the company.

Capital Product Partners L.P. (CPLP) had its price target lowered by Deutsche Bank from $9.00 to $8.00. They have a “Hold” rating on the company.

Gevo, Inc. (GEVO) had its price target boosted by UBS AG from $21.00 to $23.00. They have a “Buy” rating on the company.

Wednesday, May 11, 2011

Price Targets on (ALTH) (APEI) (BBRG) (CE) (CPLP) Updated

Price targets on shares of Allos Therapeutics Incorporated (NASDAQ: ALTH), American Public Education (NASDAQ: APEI), Bravio Brio (NASDAQ: BBRG), Celanese Co. (NYSE: CE) and Capital Product Partners L.P. (NASDAQ: CPLP) were updated by analysts.

JPMorgan Chase & Co. (NYSE:JPM) cut their price target on Allos Therapeutics Incorporated (ALTH) from $10.00 to $8.00. They have an “overweight” rating on the company.

Sterne Agee raised their price target on American Public Education (APEI) from $43.00 to $45.00. They have a “buy” rating on the company.

Morgan Keegan raised their price target on Bravio Brio (BBRG) from $22.00 to $23.00. They have an “outperform” rating on the company.

Bank of America (NYSE:BAC) raised their price target on Celanese Co. (CE) from $56.00 to $60.00. They have a “buy” rating on the company.

Deutsche Bank (NYSE:DB) raised their price target on Capital Product Partners L.P. (CPLP) from $9.00 to $10.00. They have a “hold” rating on the company.